What has changed is not the feasibility of developing drugs without complete biological knowledge, but the expectation that developers be transparent about what is and is not known, and that uncertainty be actively managed rather than minimized (ICH E9 guidance
On testing the sample, Turner found GIP to be 100 times more potent in stimulating insulin secretion in hyperglycaemic rats than his preparation of IRP (Marks 2020)
If by "wrong spot" you mean: Into muscle instead of fat: This might cause more pain and potentially faster absorption
That said, accurate product descriptions, prompt delivery, and responsive service quality increase the chances of receiving favorable reviews
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
GLP-1 receptor agonists tied to lower SUD risk: Study